We are Intuitive, a global leader in robotic-assisted minimally invasive care, pioneering technologies that empower physicians to deliver better patient outcomes. Founded in 1995 and headquartered in Sunnyvale, California, we develop, manufacture, and market innovative systems like the da Vinci surgical platform and the Ion endoluminal system, transforming surgical procedures worldwide.
Our mission drives everything we do: we believe minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, we expand the potential of physicians to heal without constraints, enabling more precise, less invasive interventions that help patients recover faster and return to their lives sooner.
The da Vinci system, our flagship technology, has revolutionized surgery across specialties including urology, gynecology, general surgery, and thoracic procedures. With advanced robotics, 3D high-definition visualization, and wristed instruments that mimic the human hand, surgeons gain enhanced capabilities for complex operations, reducing trauma, blood loss, and hospital stays.
Complementing da Vinci, our Ion system advances bronchoscopic lung biopsy, offering unprecedented access to peripheral lung nodules for early detection of lung cancer. We continuously innovate, integrating AI, data analytics, and digital solutions to support surgical teams from procedure planning to postoperative care.
Operating globally, we maintain principal offices across the United States, Europe, Asia Pacific, and beyond, marketing our products directly in key markets and through partners elsewhere. Our commitment to excellence is reflected in our public status (NASDAQ: ISRG), with thousands of employees dedicated to R&D, manufacturing, training, and customer support.
At Intuitive, we invest heavily in education and training, equipping surgeons and healthcare teams with the skills to maximize our technologies’ potential. Our vision is a future where robotic-assisted procedures are standard, making high-quality minimally invasive care accessible to millions.
We remain focused on patient safety, regulatory compliance, and evidence-based outcomes, backed by extensive clinical data and real-world experience from hundreds of thousands of procedures performed annually.